Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$132M |
| 2 |
Newmont
NEM
|
+$67.7M |
| 3 |
Corteva
CTVA
|
+$65.9M |
| 4 |
Amcor
AMCR
|
+$58.2M |
| 5 |
Alibaba
BABA
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Apple
AAPL
|
+$93M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$73.5M |
| 5 |
Pfizer
PFE
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Axogen
AXGN
$2.59B
| $1.29M | ﹤0.01% |
65,200
+5,300
| +9% | +$113K |
|
1977
MACOM Technology Solutions
MTSI
$22.7B
| $1.29M | ﹤0.01% |
85,150
+2,000
| +2% | +$30.1K |
|
|
TYPE
1978
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.29M | ﹤0.01% |
76,400
+9,400
| +14% | +$167K |
|
1979
Hanmi Financial
HAFC
$939M
| $1.28M | ﹤0.01% |
57,500
| – | – |
|
|
CSR
1980
Centerspace
CSR
$926M
| $1.27M | ﹤0.01% |
21,700
| – | – |
|
|
TPIC
1981
DELISTED
TPI Composites
TPIC
| $1.27M | ﹤0.01% |
51,400
+23,100
| +82% | +$591K |
|
|
AXDX
1982
DELISTED
Accelerate Diagnostics
AXDX
| $1.27M | ﹤0.01% |
5,550
-380
| -6% | -$74.3K |
|
|
SPWR
1983
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.27M | ﹤0.01% |
180,797
+4,123
| +2% | +$21.9K |
|
1984
Century Communities
CCS
$1.96B
| $1.26M | ﹤0.01% |
47,566
+5,500
| +13% | +$146K |
|
1985
Theravance Biopharma
TBPH
$876M
| $1.26M | ﹤0.01% |
77,342
-3,400
| -4% | -$68.9K |
|
1986
Great Southern Bancorp
GSBC
$874M
| $1.26M | ﹤0.01% |
21,000
+400
| +2% | +$22.7K |
|
1987
Community Trust Bancorp
CTBI
$1.41B
| $1.26M | ﹤0.01% |
29,690
+600
| +2% | +$24.9K |
|
1988
Marcus Corp
MCS
$921M
| $1.25M | ﹤0.01% |
38,000
+3,300
| +10% | +$121K |
|
1989
Comtech Telecommunications
CMTL
$51.5M
| $1.25M | ﹤0.01% |
44,500
+900
| +2% | +$21.8K |
|
1990
QuinStreet
QNST
$1.26B
| $1.25M | ﹤0.01% |
78,700
+6,800
| +9% | +$102K |
|
|
NPKI
1991
NPK International
NPKI
$1.15B
| $1.25M | ﹤0.01% |
168,000
+2,500
| +2% | +$19.3K |
|
1992
HealthStream
HSTM
$859M
| $1.24M | ﹤0.01% |
48,100
+900
| +2% | +$23.6K |
|
|
CLVS
1993
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.24M | ﹤0.01% |
83,550
-7,700
| -8% | -$139K |
|
1994
John B. Sanfilippo & Son
JBSS
$965M
| $1.24M | ﹤0.01% |
15,576
+500
| +3% | +$38K |
|
1995
Vanda Pharmaceuticals
VNDA
$304M
| $1.24M | ﹤0.01% |
88,100
-7,400
| -8% | -$118K |
|
1996
Voyager Therapeutics
VYGR
$195M
| $1.24M | ﹤0.01% |
45,500
+10,200
| +29% | +$233K |
|
|
RUTH
1997
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.24M | ﹤0.01% |
54,500
+1,100
| +2% | +$26.9K |
|
1998
Federal Agricultural Mortgage
AGM
$2.54B
| $1.23M | ﹤0.01% |
16,981
+400
| +2% | +$29.4K |
|
|
DBD
1999
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.23M | ﹤0.01% |
134,559
+16,100
| +14% | +$168K |
|
2000
Tootsie Roll Industries
TR
$2.97B
| $1.23M | ﹤0.01% |
41,021
+984
| +2% | +$30.8K |
|
Similar funds
Swiss National Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Swiss National Bank held 2,619 positions worth $92.7B, up 1.7% from $91.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q2 2019 filing shows 112 new, 1,554 increased, 696 reduced and 65 closed positions. Its largest new stake was Dow Inc: 2,494,044 shares worth $123M. The largest sale was DuPont de Nemours, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2019 buy was Dow Inc: 2,494,044 shares worth $123M.
- Swiss National Bank added most to Newmont in Q2 2019, an estimated $67.7M increase.
- Swiss National Bank's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $128M.
- Swiss National Bank fully exited Goldcorp Inc in Q2 2019, selling an estimated $78.3M.
- Swiss National Bank's ten largest holdings make up 18% of its $92.7B portfolio in Q2 2019.
- Swiss National Bank opened 112 new positions and closed 65 in Q2 2019.
- Swiss National Bank's portfolio value rose 1.7% quarter-over-quarter to $92.7B.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.